Showing results (171-180 of 510) with videos related to
Sort By:
Pageof 51
Human Gene Therapy|August 23, 2012
Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factorEmma Chan, Torsten Schaller, Ayad Eddaoudi, et al.Haematologica|December 3, 2011
Tyrosine phosphorylation of WASP promotes calpain-mediated podosome disassemblyLee Macpherson, James Monypenny, Michael P Blundell, et al.Cell Reports|March 9, 2022
Critical role of WASp in germinal center tolerance through regulation of B cell apoptosis and diversificationMarc Descatoire, Remi Fritzen, Samuel Rotman, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 11, 2016
Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literatureChih-An Chen, Wan-Chen Chung, Yuan-Yow Chiou, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressorJared E Lopes, Troy R Torgerson, Lisa A Schubert, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 16, 2005
Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cellsElena K Siapati, Brian W Bigger, James Miskin, et al.Nature Materials|January 8, 2013
The cytoplasm of living cells behaves as a poroelastic materialEmad Moeendarbary, Léo Valon, Marco Fritzsche, et al.Human Gene Therapy|February 5, 2008
Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome proteinMiguel G Toscano, Cecilia Frecha, Karim Benabdellah, et al.European Journal of Immunology|June 20, 2014
Exacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: modulatory role of regulatory B cellsGerben Bouma, Natalie A Carter, Mike Recher, et al.Human Gene Therapy|January 22, 2024
CRISPR/Cas9-Based Disease Modeling and Functional Correction of Interleukin 7 Receptor Alpha Severe Combined Immunodeficiency in T-Lymphocytes and Hematopoietic Stem CellsRajeev Rai, Zohar Steinberg, Marianna Romito, et al.Pageof 51